Earnings Per Share, Basic in USD/shares of Ernexa Therapeutics Inc. from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Ernexa Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2010 to Q3 2025.
  • Ernexa Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.15 USD/shares, a 99.8% increase year-over-year.
  • Ernexa Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 86 USD/shares.
  • Ernexa Therapeutics Inc. annual Earnings Per Share, Basic for 2024 was -3.26 USD/shares, a 20.1% increase from 2023.
  • Ernexa Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -4.08 USD/shares, a 49.4% increase from 2022.
  • Ernexa Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -8.06 USD/shares, a 85.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Ernexa Therapeutics Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $86.00 $0 +$73.60 +99.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 $12.00 -$1 +$14.70 +96% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 -$2 $0 +$1.08 +87.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 -$3 $87.00 +$88.20 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-12
Q3 2024 -$91 -$74 -$73 -7055% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 -$18 -$15 -$15 -1705% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 -$4 -$1 $0 -16% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 -$4 -$1 $0 -25.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-12
Q3 2023 -$3 -$1 +$1.46 +58.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$5 -$1 +$0.31 +26.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5 -$1 +$2.44 +69.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$8 -$1 +$20.80 +95.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$28 -$2 +$31.50 +92.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$60 -$1 -$1 -383% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$59 -$4 -$3 -422% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$56 -$22 -$22 -17958% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$35 -$34 -$34 -30836% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1 $0 $0 -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$1 -$1 -$1 -1017% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-01
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2018 $0.08 +$0.15 Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q3 2013 $0 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q3 2012 $0 +$0.01 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q3 2011 $0 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q3 2010 $0 Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14

Ernexa Therapeutics Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3 +$0.82 +20.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-12
2023 -$4 +$3.98 +49.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-12
2022 -$8 +$48.60 +85.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$57 -$56 -13707% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.